EGFR and colorectal carcinoma: In this article, we will discuss targeted therapies for CRC based on the epidermal growth factor receptor (EGFR) signaling pathway and review published data about the potential usefulness of the downstream oncogene Kirsten ras (KRAS) as a biological marker for response to these therapies.